What is NeuroFlow?
NeuroFlow operates at the intersection of behavioral health and digital infrastructure, providing a comprehensive platform designed to connect patients with care providers and specialists. Unlike traditional digital health tools that focus solely on patient-facing self-care, NeuroFlow creates a robust ecosystem that empowers healthcare organizations to remotely coordinate and deliver mental health services at scale. By focusing on the integration of behavioral health into primary care, the company addresses critical gaps in the healthcare delivery system, ensuring that patients receive timely support while providers gain actionable insights into patient outcomes. This platform-centric approach positions NeuroFlow as a vital partner for healthcare leaders aiming to improve clinical efficacy and operational efficiency in an increasingly complex medical environment.
How much funding has NeuroFlow raised?
NeuroFlow has raised a total of $52.5M across 3 funding rounds:
Series A
$7.5M
Series B
$20M
Other Financing Round
$25M
Series A (2019): $7.5M with participation from Red & Blue Ventures, AWT Private Investments, Spring Point Partners, Dreamit Ventures, and Builders VC
Series B (2021): $20M led by Magellan Health, Inc.
Other Financing Round (2022): $25M supported by SEMCAP Health
Key Investors in NeuroFlow
Builders VC
Builders VC is a venture capital firm focused on modernizing antiquated industries by investing in innovative technologies and solutions. They support founders who tackle complex problems and aim to reshape systems across various sectors, including construction, healthcare, and agriculture.
Red & Blue Ventures
A venture capital firm that specializes in early-stage investments, often focusing on university-affiliated startups and high-growth technology companies.
Dreamit Ventures
A growth-focused venture firm that provides startups with access to customers, coaching, and capital to accelerate their market entry and scaling efforts.
What's next for NeuroFlow?
With the recent infusion of capital, NeuroFlow is well-positioned to scale its enterprise operations and deepen its technological capabilities. The strategic focus will likely center on expanding its network of clinical partners and enhancing the platform's data analytics features to provide more granular insights into patient progress. As the healthcare industry continues to prioritize mental health, NeuroFlow's ability to facilitate remote care coordination will be a key differentiator. The company is expected to leverage this financing to refine its digital health tools, ensuring they remain at the forefront of clinical innovation while maintaining the high standards of security and interoperability required by large-scale healthcare systems. Future growth will likely involve further integration with electronic health records and the expansion of its behavioral health management suite to meet the evolving needs of diverse patient populations.
See full NeuroFlow company page
